Revvity (RVTY) Asset Writedowns and Impairment (2013 - 2023)

Revvity (RVTY) posted Asset Writedowns and Impairment of -$3.9 million for Q1 2023, down 148.73% quarter-over-quarter from $7.9 million in Q1 2021.

Revvity (RVTY) Asset Writedowns and Impairment (2013 - 2023) Analysis & Trends

Revvity (RVTY) has reported Asset Writedowns and Impairment for 3 consecutive years, with -$3.9 million the latest figure, recorded in Q1 2023.

  • Asset Writedowns and Impairment for Q1 2023 came in at -$3.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $4.3 million (changed N/A YoY), and the FY2025 annual result was $4.8 million, down 79.03% from the prior year.
  • Asset Writedowns and Impairment was -$3.9 million for Q1 2023 at Revvity, down from $7.9 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $7.9 million in Q1 2021 and troughed at -$3.9 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Revvity 12.62 Bn 11.76 Bn 387.66 Mn

Historic Data

Download Data
DateValue
Jan 1, 2023 -3.87 Mn
Jan 1, 2023 -3.87 Mn
Jan 3, 2021 7.94 Mn
Jan 3, 2021 7.94 Mn
Dec 29, 2013 200,000.00
Dec 29, 2013 200,000.00